
Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced it will sponsor Citizen Scientist: Unpacking the …